Amendment and Mail Process Complete

KYZATREX

Marius Pharmaceuticals LLC

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88826033 FILING DATE 03/09/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY ERVIN, INGA MARIE
L.O. ASSIGNED 111

PUB INFORMATION

RUN DATE 07/31/2020
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 07/30/2020
LITERAL MARK ELEMENT KYZATREX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT KYZATREX
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Marius Pharmaceuticals LLC
ADDRESS 8601 Six Forks Road
8601 Six Forks Road, Suite 630
Raleigh, NC 27609
ENTITY 16-LTD LIAB CO
CITIZENSHIP Delaware
DBA/AKA DBA Marius Pharmaceuticals LLC

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations, namely, testosterone and testosterone pro-drugs for the treatment of sub optimal levels of testosterone, primary and secondary hypogonadism, gynecological disorders, inflammatory diseases, cardiovascular disorders, frailty, and symptoms of COVID-19

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
07/30/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 016
07/30/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 015
07/24/2020 ALIE A ASSIGNED TO LIE 014
07/23/2020 DOCK D ASSIGNED TO EXAMINER 013
07/10/2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 012
06/23/2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED 011
06/23/2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED 010
06/23/2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 009
06/23/2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 008
06/23/2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED 007
06/04/2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
06/04/2020 GNRT F NON-FINAL ACTION E-MAILED 005
06/04/2020 CNRT R NON-FINAL ACTION WRITTEN 004
05/29/2020 DOCK D ASSIGNED TO EXAMINER 003
03/13/2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/12/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jeffrey J. Ellison
CORRESPONDENCE ADDRESS Jeffrey J. Ellison
Clark+Elbing LLP
101 Federal Street, 15th Floor
Boston MA 02110
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed